Reviva Pharmaceuticals Holdings, Inc. (RVPHW)

Market Cap	31.30M
Revenue (ttm)	n/a
Net Income (ttm)	-27.11M
Shares Out	68.00M
EPS (ttm)	-0.64
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	32,146
Open	0.0799
Previous Close	0.0607
Day's Range	0.0600 - 0.0799
52-Week Range	0.0226 - 0.7800
Beta	-0.05
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 14, 2025

About RVPHW

Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company’s lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dem...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2018
• Employees: 14
• Stock Exchange: NASDAQ
• Ticker Symbol: RVPHW
• Website: https://www.revivapharma.com